Summary:
A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Adaptive
Dose-Finding Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive
Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have
Responded Inadequately to Antidepressant Therapy
Qualified Participants Must:
• Male or female patients aged 18 to 70
Qualified Participants May Receive:
Compensation for time and travel